EurekAlert! -
12 Feb 2021 07:00
(University Health Network) Inhibiting a key enzyme that controls a large network of proteins important in cell division and growth paves the way for a new class of drugs that could stop glioblastoma, a deadly brain cancer, from growing.
Share this Article